Cardiovascular disease is one of the leading causes of mortality and morbidity in postmenopausal women. Menopausal changes have been shown to be related with an atherogenic lipid profile. The efficiency of statins in reducing the incidence of cardiovascular diseases has been well documented in a variety of randomized, placebo controlled trials. This review outlines the effectiveness of statins both in cardiac events and in some noticeable indications in postmenopausal women.
Keywords: Anticholesteremic agents, cardiovascular diseases/prevention & control, hydroxymethylglutaryl-CoA reductase inhibitors/therapeutic use, postmenopause; primary prevention.Copyright © 2025 Archives of the Turkish Society of Cardiology